Cardiac Booster develops a next-generation, high-flow, low-profile percutaneous ventricular assist device (pVAD). This minimally invasive device provides temporary hemodynamic support for patients experiencing cardiogenic shock or undergoing high-risk PCI. The technology aims to improve patient outcomes by offering effective cardiac assistance with reduced procedural invasiveness.
Funding
Funding not disclosed
Founders
Product
Problem
Patients experiencing cardiogenic shock or undergoing high-risk percutaneous coronary interventions (PCI) often require temporary hemodynamic support due to the heart's inability to pump sufficient blood. Current solutions may be too invasive, leading to complications and prolonged recovery times.
Solution
CardiacBooster is developing a high-flow, low-profile percutaneous left ventricular assist device (pVAD) designed to provide temporary cardiac support. This minimally invasive device is inserted through blood vessels in the groin, offering an alternative to more invasive surgical procedures. The pVAD aims to enhance cardiac function during periods of hemodynamic instability, specifically for patients in cardiogenic shock or undergoing high-risk PCI. By minimizing invasiveness, CardiacBooster intends to improve patient outcomes and reduce the risks associated with traditional cardiac support methods.
Target Audience
The primary target audience includes interventional cardiologists and cardiac surgeons treating patients experiencing cardiogenic shock or undergoing high-risk PCI.
Features
- Percutaneous delivery for minimally invasive insertion.
- High-flow design to provide adequate hemodynamic support.
- Low-profile construction to minimize vascular complications.
- Designed for temporary support during cardiogenic shock.
- Intended for use during high-risk percutaneous coronary interventions (PCI).